Mutlu, H. Et Al. 2015. Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer. Journal of Oncology Pharmacy Practice , vol.21, no.1 , 72-73.

Mutlu, H., Büyükçelik, A., Akça, Z., & Erden, A., (2015). Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer. Journal of Oncology Pharmacy Practice , vol.21, no.1, 72-73.

Mutlu, Hasan Et Al. "Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer," Journal of Oncology Pharmacy Practice , vol.21, no.1, 72-73, 2015

Mutlu, Hasan Et Al. "Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer." Journal of Oncology Pharmacy Practice , vol.21, no.1, pp.72-73, 2015

Mutlu, H. Et Al. (2015) . "Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer." Journal of Oncology Pharmacy Practice , vol.21, no.1, pp.72-73.

@article{article, author={Hasan Mutlu Et Al. }, title={Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer}, journal={Journal of Oncology Pharmacy Practice}, year=2015, pages={72-73} }